Dermatology

Cutaneous Lymphomas

Questions discussed in this category

When is mechlorethamine better than more common treatments like light therapy and topical steroids for mycosis fungoides?

3 Answers available

How often do you pursue malignant transformation screening In patients with lymphomatoid papulosis or pityriasis lichenoides?

And what workup do you pursue?

1 Answer available

How do you approach balancing the potential risk of worsening actinic damage and maintaining CTCL clearance in patients treated with nb-UVB?

2 Answers available

How do you approach screening for additional malignancies in patients with a history of CTCL?

There have been reports suggesting that patients with CTCL may be at increased risk for other malignancies.

2 Answers available

What first-line therapies do you recommend for patients with folliculotropic mycosis fungoides?

Has topical dapsone worked?

3 Answers available

Do you hold histone deacetylase (HDAC) inhibitors for patients receiving palliative radiation therapy for cutaneous lymphomas?

If so, how long before/after radiation?

1 Answer available

When should you discontinue narrow band UVB when a patient is in clinical remission from patch stage mycosis fungoides?

3 Answers available

How do you differentiate erythrodermic mycosis fungoides and Sezary syndrome - is it primarily based on the burden of blood involvement of malignant cells?

Mycosis fungoides and Sezary syndrome are thought to be distinct genotypically and phenotypically. It is my understanding that Sezary syndrome typical...

2 Answers available

Related Topics in Dermatology